Posted Mar. 29, 2012 at 6:28 a.m.

Premium Lock FDA rejects Charlotte firm's drug to treat Parkinson's condition

Published: 2012-03-29 06:28:58
Updated: 2012-03-29 06:28:58

FDA approval

However, a door to approval remains cracked open for the company. The FDA's complete response letter asks for more data on the durability of Northera over a two- to three-month period....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll